Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Director/PDMR Shareholding

27 Nov 2015 10:00

RNS Number : 2011H
Creston PLC
27 November 2015
Β 

27 November 2015

Β 

Β 

Creston plc

Β 

Β 

Β 

('Creston' or the 'Group')

Β 

Grant of Awards to Executive Directors under the Long Term Incentive Plan

Β 

Creston plc (LSE: CRE) announces that, on 27 November 2015, the Group granted the following conditional share awards (the "Awards") to the Executive Directors under the Creston Long Term Incentive Plan 2015 ("LTIP") approved by shareholders at the 2015 Annual General Meeting. The Awards were granted at a share price of 121.75 pence per ordinary share (being the average of the middle market quotations of the Company's shares during a period of 3 dealing days immediately prior to the date of grant) as set out below:

Β 

Name

Award Type

Number of ordinary shares subject to LTIP Award

Market value of shares at the date of the Award (Β£)

Barrie Brien

Core Award

312,114

380,000

Barrie Brien

Stretch Award

312,114

380,000

Kathryn Herrick

Core Award

94,455

115,000

Kathryn Herrick

Stretch Award

94,455

115,000

Β 

After granting the Awards the Executive Directors now hold the following beneficial interests:

Β 

Name

Number of conditional shares held following Award

Number of ordinary shares currently held

Total shareholding of currently held shares (%)

Barrie Brien

1,156,118

355,230

0.61%

Kathryn Herrick

292,196

5,700

0.01%

Β 

The conditional shares granted under the Awards will normally vest on 12 June 2018, subject to the satisfaction of the stretching performance conditions applying to the respective Core and Stretch Awards and are then required to be held for a further two years.

Β 

The performance criteria for which the Core Awards are based on is the performance of the Group's diluted earnings per share over the three year performance period (being the financial years ending 31 March 2017, 2018, and 2019). The performance criteria for which the Stretch Awards are based on is the performance of the Group's relative Total Shareholder Return ("TSR") over the three year performance period (being the financial years ending 31 March 2017, 2018, and 2019). The Group's TSR must exceed the median ranking of the TSR of a comparator group comprising the constituents of the FTSE SmallCap for the award to begin vesting. The award will then vest on a straight line basis from 0 per cent to 100 per cent as the Group's TSR ranks from the median TSR up until the upper decile TSR ranking. See the Directors' Remuneration Report within the FY15 Annual Report and Accounts for further detail.

Β 

No consideration will be paid for the conditional shares upon vesting.

Β 

For further information please contact:

Β 

Creston plc

Barrie Brien, Group Chief Executive

+44 (0)20 7930 9757

Kathryn Herrick, Chief Financial Officer

Bell Pottinger

+44 (0)20 3772 2491

Elly Williamson/Lucy Stewart

Β 

Β 

About Creston plc

Creston plc (LSE: CRE), incorporating the Creston Unlimited group offer, is a marketing communications group delivering a range of digital technology-based marketing solutions to blue-chip global clients. Encompassing consultants and discipline experts from across the industry and beyond, Creston Unlimited unlocks the power of creative collaboration to realise the opportunities that exist for brands and businesses in today's rapidly evolving world. www.creston.com / www.creston-unlimited.comΒ 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSKMMZMLNKGKZG
Date   Source Headline
27th Jun 20113:11 pmRNSHolding(s) in Company
23rd Jun 20113:59 pmRNSHolding(s) in Company
23rd Jun 201112:40 pmRNSHolding(s) in Company
21st Jun 20113:21 pmRNSHolding(s) in Company
21st Jun 20117:00 amRNSFinal Results
20th Jun 20115:46 pmRNSHolding(s) in Company
10th Jun 20117:00 amRNSDirectorate Change
10th May 20119:59 amRNSAnnual Information Update
10th May 20117:00 amRNSInvestor & Analyst Presentation
20th Apr 20117:00 amRNSTrading Statement
13th Apr 201112:14 pmRNSHolding(s) in Company
7th Apr 20114:02 pmRNSHolding(s) in Company
17th Feb 20112:28 pmRNSHolding(s) in Company
16th Feb 20112:21 pmRNSHolding(s) in Company
16th Feb 201112:39 pmRNSHolding(s) in Company
3rd Feb 20117:00 amRNSInterim Management Statement
5th Jan 20113:10 pmRNSNotice of Interim Management Statement
22nd Dec 20109:56 amRNSCompletion of Acquisition
15th Dec 201012:40 pmRNSResult of Meeting
30th Nov 20107:00 amRNSInterim Results
30th Nov 20107:00 amRNSAcquisition
8th Nov 20102:18 pmRNSHolding(s) in Company
19th Oct 20101:09 pmRNSHolding(s) in Company
19th Oct 20101:07 pmRNSHolding(s) in Company
11th Oct 201011:12 amRNSNotice of Interim Results
28th Sep 20108:00 amRNSCreation of E-Healthcare Start-Up
2nd Sep 201010:55 amRNSAGM Statement
26th Jul 20107:00 amRNSInterim Management Statement
14th Jul 20104:12 pmRNSDirector/PDMR Shareholding
14th Jul 201011:54 amRNSDisposal
13th Jul 20109:51 amRNSResult of General Meeting
28th Jun 20104:30 pmRNSPosting of Circular
28th Jun 201010:35 amRNSHolding(s) in Company
28th Jun 20107:01 amRNSDisposal
28th Jun 20107:00 amRNSFinal Results
26th May 20104:52 pmRNSHolding(s) in Company
26th May 20108:40 amRNSNotice of Results
21st May 201012:56 pmRNSHolding(s) in Company
13th May 20105:46 pmRNSHolding(s) in Company
26th Apr 20102:13 pmRNSHolding(s) in Company
22nd Apr 20103:05 pmRNSHolding(s) in Company
20th Apr 20107:00 amRNSPre-Close Trading Statement
6th Apr 20104:29 pmRNSDirector/PDMR Shareholding
6th Apr 20104:26 pmRNSDirector/PDMR Shareholding
23rd Mar 20104:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20104:41 pmRNSDirector/PDMR Shareholding
17th Feb 20105:51 pmRNSHolding(s) in Company
3rd Feb 20107:00 amRNSInterim Management Statement
10th Dec 20097:33 amRNSDirector/PDMR Shareholding
2nd Dec 20097:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.